NCT01424514View on ClinicalTrials.gov

SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

December 1, 2010

Primary Completion Date

April 1, 2011

Study Completion Date

April 18, 2011

Conditions

Rhinitis

Interventions

DRUG

SB-705498

12mg intra nasal

DRUG

Placebo

Placebo intra nasal

Trial Locations (1)

L4W 1N2

GSK Investigational Site, Mississauga

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01424514 - SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis | Biotech Hunter | Biotech Hunter